---

Anti-mullerian hormone as a diagnostic marker in women with polycystic ovary syndrome

---

Original Article

Author Details : Iram Shabir, Sheikh Ishaq, Arif Akbar Bhat, Roohi Ashraf, Sabhiya Majid

Volume : 3, Issue : 4, Year : 2016

Article Page : 303-306

Suggest article by email

Get Permission

---

Abstract

Plasma levels of AMH in women serves as an important biomarker of ovarian reserves and indicates the small follicular growth. The reproductive span in healthy women is predicted by progressive age related decline of plasma AMH levels. The values are low in the clinical condition of diminished ovarian reserve, indicating the presence of few remaining follicles within the ovary. Recent studies have also shown the importance of this hormone in various pathological conditions of ovary including PCOS. In women with PCOS, the small ovarian antral follicles increase and AMH secreted by these developing follicles can be used as an important marker to detect follicular impairment. It is suggested that the increased secretion of LH and/or testosterone may have a positive effect on the secretion of AMH by the ovarian follicles. A positive correlation has also been found between high AMH levels and androgen over-production due to intrinsic defects of thecal cells. In conclusion, high AMH levels have been predicted as a response to various treatments of PCOS, while improvement in various clinical and biochemical parameters have been associated with decline in AMH, thus supporting a very important role of AMH in diagnosis and treatment of PCOS.

Keywords: Anti-mullerian hormone; anovulation; Body mass Index; Polycystic ovary syndrome

How to cite : Shabir I, Ishaq S, Bhat A A, Ashraf R, Majid S, Anti-mullerian hormone as a diagnostic marker in women with polycystic ovary syndrome. Indian J Obstet Gynecol Res 2016;3(4):303-306

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.